Bill
Bill > S07753
NY S07753
NY S07753Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.
summary
Introduced
11/15/2023
11/15/2023
In Committee
01/03/2024
01/03/2024
Crossed Over
Passed
Dead
12/31/2024
12/31/2024
Introduced Session
2023-2024 General Assembly
Bill Summary
AN ACT to amend the public health law, in relation to the classification of the drug xylazine as a controlled substance; and to amend the penal law, in relation to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine
AI Summary
This bill amends the New York Public Health Law to classify the drug xylazine as a Schedule I controlled substance. It also amends the New York Penal Law to include xylazine or preparations, compounds, mixtures, or substances containing xylazine as "adulterant depressants," which are subject to criminal penalties for the sale and possession of such substances. The bill aims to address the increasing use and distribution of xylazine, a veterinary sedative that has been found in a growing number of overdose deaths, by adding it to the list of controlled substances and establishing criminal sanctions for its unauthorized possession and sale.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
REFERRED TO HEALTH (on 01/03/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2023/S7753 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=S07753&term=2023&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#S07753 |
Loading...